Menu

  1. Home
  2.  / 
  3. Glaucoma - I, Free Paper
  4.  / 
  5. FP1894 : Outcomes of High dose(40mcg) injectable subconjunctival MMC in failing or failed blebs

Share this post

Dr. MADHAVI RAMANATHA PILLAI

Dr. DEVENDRA MAHESHWARI, DR. GEETHU KURIAN, DR. DRISHTI

Abstract

Aim:To evaluate outcomes of High dose(40mcg) injectable subconjunctival MMC in failing or failed blebs.Methods:Prospective study.30 eyes of 30 consecutive patients,who had undergone trabeculectomy(>6weeks &amp;<1 year)&amp; had flat bleb/tenon’s cyst/high IOP requiring medications were selected.These patients were given high dose(40mcg) injectable subconjunctival MMC along with needling.Baseline &amp; follow up visits were compared to find out the significant difference in AGM, IOP and BCVA Results: Mean (SD) of the age is 59.93 (9.7) years.The IOP decreased from 24.72+/-6.5mmHg (range12–43)to 17.52+/-4.2mmHg (range13–28) after injection at last follow‑up (P < .0001).AGM reduced from median1.00+/-0.98(range 0–3) to Median1.96+/-1.11(P=0.050,range 0-4) at the final visit.Overall success rate was 78.2% after 1year.There were no complications post injection Conclusion:High dose injectable subconjunctival MMC appears to be a good option for rescuing failing blebs &amp; avoids need for repeat major surgery

Full Text  

 

Leave a Comment